Patient Summary

Displaying 1 - 12 out of 12 topics found with matching tool types

    Brain Injury and Brain Death

  1. Practice guideline: Reducing brain injury after cardiopulmonary resuscitation

    May 2017

  2. Summary of Evidence-based Guideline Update: Evaluation and Management of Concussion in Sports

    March 2013

  3. Update: Determining Brain Death in Adults

    June 2010

  4. Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation

    July 2006

  5. Child Neurology

  6. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis

    October 2016

  7. Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy

    February 2016

  8. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

    March 2015

  9. Summary of Evidence-based Guideline Update: Evaluation and Management of Concussion in Sports

    March 2013

  10. Update: Medical Treatment of Infantile Spasms

    June 2012

  11. Evidence Report: Genetic and Metabolic Testing on Children with Global Developmental Delay

    October 2011

  12. Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy

    January 2010

  13. Evaluation of the child with microcephaly

    September 2009

  14. Diagnostic Assessment of the Child with Status Epilepticus

    November 2006

  15. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

  16. Diagnostic Assessment of the Child with Cerebral Palsy

    March 2004

  17. Evaluation of the Child with Global Developmental Delay

    February 2003

  18. Screening and Diagnosis of Autism

    August 2000

  19. Dementia

  20. Practice Guideline Update Summary: Mild Cognitive Impairment

    December 2017

  21. Diagnostic Accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease

    October 2012

  22. Update: Evaluation and Management of Driving Risk in Dementia

    April 2010

  23. Diagnosis of Dementia

    May 2001

  24. Endorsed or Affirmed Statements

  25. Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department

    February 2013

  26. Epilepsy

  27. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors

    April 2017

  28. Practice Guideline Summary: Use of fMRI in the Presurgical Evaluation of Patients with Epilepsy

    January 2017

  29. Evidence-based Guideline: Management of an Unprovoked First Seizure in Adults

    April 2015

  30. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  31. Update: Vagus Nerve Stimulation for the Treatment of Epilepsy

    August 2013

  32. Treatment of Parenchymal Neurocysticercosis

    April 2013

  33. Update: Medical Treatment of Infantile Spasms

    June 2012

  34. Antiepileptic Drug Selection for People with HIV/AIDS

    January 2012

  35. Women with Epilepsy: Drug Risks and Safety during Pregnancy

    April 2009

  36. Women with Epilepsy: Drug Risks during Pregnancy

    April 2009

  37. Evaluating an apparent unprovoked first seizure in adults

    November 2007

  38. Diagnostic Assessment of the Child with Status Epilepticus

    November 2006

  39. Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy

    April 2004

  40. Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment of Refractory Epilepsy

    April 2004

  41. Temporal Lobe and Localized Neocortical Resections for Epilepsy

    April 2004

  42. Headache

  43. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  44. Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults

    April 2012

  45. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

  46. Movement Disorders

  47. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

  48. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  49. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  50. Treatment of Tardive Syndromes

    July 2013

  51. Pharmacologic Treatment of Chorea in Huntington Disease

    August 2012

  52. Update: Treatment of Essential Tremor

    October 2011

  53. Treatment of Nonmotor Symptoms of Parkinson Disease

    March 2010

  54. Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease

    April 2006

  55. Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesias

    April 2006

  56. Multiple Sclerosis

  57. Summary of Comprehensive Systematic Review: Rehabilitation in Multiple Sclerosis

    November 2015

  58. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  59. Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis

    March 2014

  60. Assessment and Management of Psychiatric Disorders in Individuals with Multiple Sclerosis

    December 2013

  61. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

  62. Evidence Report: The Efficacy and Safety of Mitoxantrone (Novantrone) in the Treatment of Multiple Sclerosis

    May 2010

  63. Neutralizing Antibodies to Interferon-beta: Assessment of their Clinical and Radiographic Impact

    August 2007

  64. Neuromuscular

  65. Practice advisory: Etanercept for poststroke disability

    June 2016

  66. Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy

    February 2016

  67. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Facioscapulohumeral Muscular Dystrophy

    July 2015

  68. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

    March 2015

  69. Evidence-based Guideline Summary: Diagnosis and Treatment of Limb-girdle and Distal Dystrophies

    October 2014

  70. Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders

    March 2012

  71. Update: Intraoperative Spinal Monitoring with Somatosensory and Transcranial Electrical Motor Evoked Potentials

    February 2012

  72. Treatment of Painful Diabetic Neuropathy

    April 2011

  73. Symptomatic Treatment for Muscle Cramps

    February 2010

  74. Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Drug, Nutritional, and Respiratory Therapies

    October 2009

  75. Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, and Cognitive/Behavioral Impairment

    October 2009

  76. Evaluation of Distal Symmetric Polyneuropathy: Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy

    January 2009

  77. Utility of Surgical Decompression for Treatment of Diabetic Neuropathy

    June 2006

  78. Immunotherapy for Guillain-Barre Syndrome

    September 2003

  79. Other

  80. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

  81. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  82. Update: Steroids and Antivirals for Bell Palsy

    November 2012

  83. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

  84. The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia

    October 2008

  85. Therapies for benign paroxysmal positional vertigo

    May 2008

  86. Assessing Your Risk For Falls

    February 2008

  87. Use of epidural steroid injections to treat radicular lumbosacral pain

    August 2007

  88. Treatment of Nervous System Lyme Disease

    July 2007

  89. Treatment of Postherpetic Neuralgia

    September 2004

  90. Stroke and Vascular Neurology

  91. Practice Advisory: Recurrent Stroke with Patent Foramen Ovale (Update of Practice Parameter)

    July 2016

  92. Practice advisory: Etanercept for poststroke disability

    June 2016

  93. Summary of Evidence-based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation

    February 2014

  94. Periprocedural Management of Antithrombotic Medications in Patients with Ischemic Cerebrovascular Disease

    May 2013

  95. Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department

    February 2013

  96. Carotid Endarterectomy

    September 2005

  97. Technology Assessments

  98. Practice Guideline: Cervical and Ocular Vestibular Evoked Myogenic Potential Testing

    November 2017

  99. Practice Guideline Summary: Use of fMRI in the Presurgical Evaluation of Patients with Epilepsy

    January 2017

  100. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis

    October 2016

  101. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response

    December 2015

  102. Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders

    March 2012

  103. Update: Intraoperative Spinal Monitoring with Somatosensory and Transcranial Electrical Motor Evoked Potentials

    February 2012

  104. Update: Plasmapheresis in Neurologic Disorders

    January 2011

  105. Botulinum neurotoxin for the treatment of movement disorders

    May 2008

  106. Botulinum neurotoxin in the treatment of autonomic disorders and pain

    May 2008

  107. Botulinum neurotoxin for the treatment of spasticity

    May 2008

  108. Carotid Endarterectomy

    September 2005

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer